Application
Western blot analysis of MACOI Antibody (N-term) (Cat. #AP4951a) in HL-60 cell line lysates (35ug/lane). MACOI (arrow) was detected using the purified Pab.Application
MACOI Antibody (N-term) (Cat. #AP4951a) flow cytometric analysis of HL-60 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | MACOI Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | TMEM57; Macoilin; Transmembrane protein 57 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBFC |
| WB:1:100~500 FC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | TMEM57 Macoilin Transmembrane protein 57 |
|---|---|
| Molecular Weight(MW) | 76178 Da |
| Tissue Specificity | This MACOI antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between amino acid 240-270 from the N-terminal region of human MACOI. |
| Cellular Localization | Nucleus membrane; Multi-pass membrane protein (By similarity). Cell projection, axon (By similarity) Note=Detected in the nucleus membrane of non-neuronal cells and in axonal outgrowths of neuronal cells (By similarity) |
| Entrez Gene | 55219 |
|---|
Application
Western blot analysis of MACOI Antibody (N-term) (Cat. #AP4951a) in HL-60 cell line lysates (35ug/lane). MACOI (arrow) was detected using the purified Pab.
Application
MACOI Antibody (N-term) (Cat. #AP4951a) flow cytometric analysis of HL-60 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 FC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
